swot-logo

GeneDx Holdings Corp - Ordinary Shares - Class A SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

GeneDx Holdings Corp - Ordinary Shares - Class A has 32 Strengths, 6 Weaknesses, 6 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

High Normalized Momentum Score

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Stocks whose current price is 20% higher than week low, and more than previous close

Weekly Strategy: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Relative Outperformance versus Industry over 1 Month

Near 52 Week High

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Companies with reducing Debt

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Top Gainers

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter